Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

12.68USD
29 Aug 2014
Price Change (% chg)

$0.33 (+2.67%)
Prev Close
$12.35
Open
$12.43
Day's High
$12.73
Day's Low
$12.41
Volume
2,348,301
Avg. Vol
2,319,827
52-wk High
$14.07
52-wk Low
$10.54

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions,... (more)

Overall

Beta: 1.06
Market Cap (Mil.): $16,809.97
Shares Outstanding (Mil.): 1,325.71
Dividend: --
Yield (%): --

Financials

Search Stocks

Cyberonics device improves heart function after Boston flop

BARCELONA - A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific.

01 Sep 2014

Cyberonics device improves heart function after Boston flop

BARCELONA, Sept 1 - A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific.

01 Sep 2014

Boston Scientific nerve device no help in heart failure study

BARCELONA - A Boston Scientific device that stimulates the vagus nerve – a superhighway connecting the brain to the rest of the body - failed to help patients with heart failure in a mid-stage clinical trial.

30 Aug 2014

Boston Scientific nerve device no help in heart failure study

BARCELONA, Aug 30 - A Boston Scientific device that stimulates the vagus nerve - a superhighway connecting the brain to the rest of the body - failed to help patients with heart failure in a mid-stage clinical trial.

30 Aug 2014

Boston Scientific wins first trial over transvaginal mesh device

- A Massachusetts jury has cleared Boston Scientific Corp of selling dangerous and defective transvaginal mesh devices, in the first out of more than 20,000 lawsuits waiting to go to trial.

30 Jul 2014

Boston Scientific wins first trial over transvaginal mesh device

July 30 - A Massachusetts jury has cleared Boston Scientific Corp of selling dangerous and defective transvaginal mesh devices, in the first out of more than 20,000 lawsuits waiting to go to trial.

30 Jul 2014

UPDATE 2-Boston Scientific profit exceeds expectations as sales rise

July 24 - Boston Scientific Corp, which makes medical equipment, on Thursday reported a slightly higher-than-expected quarterly profit as improvements in its heart device business helped drive revenue up 4 percent.

24 Jul 2014

Boston Scientific reports profit as sales rise

July 24 - Boston Scientific, which makes medical equipment, on Thursday reported a better-than-expected profit as sales across all sectors including its large heart device business improved by 4 percent on a constant currency basis.

24 Jul 2014

Fitch Affirms Boston Scientific's IDR at 'BBB-'; Outlook Stable

(The following statement was released by the rating agency) CHICAGO, July 09 (Fitch) Fitch Ratings has affirmed Boston Scientific Corp.'s (NYSE: BSX) long-term IDR at 'BBB-' with a Stable Outlook. A full list of BSX's ratings follows at the end of this release. The rating action applies to approximately $4.25 billion of debt. KEY RATING DRIVERS: --Fitch expects BSX will operate with relatively stable leverage (total debt/EBITDA) of 2.3x-2.5x during the next 12 months, despite a challenging

09 Jul 2014

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, June 17,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Res

17 Jun 2014

Competitors

  Price Change
Abbott Laboratories (ABT.N) $42.24 -0.11
Medtronic, Inc. (MDT.N) $63.85 +0.73
St. Jude Medical, Inc. (STJ.N) $65.59 +0.72

Earnings vs. Estimates

Search Stocks